Author: Simon Rasalingham, 2026 On my first visit to the FDA, driving up to the entrance, I wondered why there were men with semi-automatic weapons at the gate. Then I took my shoes off to get through security, to attend a meeting about clearing an algorithm. The meeting was my team on one side and two rows of FDA people on the other. For a first meeting. That is where most British founders' regulatory strategy gets decided. It is very intimidating, and it can put you off for